Literature DB >> 15816784

Female reproductive cycle and obsessive-compulsive disorder.

Javier Labad1, José Manuel Menchón, Pino Alonso, Cinto Segalàs, Susana Jiménez, Julio Vallejo.   

Abstract

BACKGROUND: The aim of our study was to assess whether there is a relationship between reproductive cycle events and the initiation or changes in symptoms of obsessive-compulsive disorder (OCD).
METHOD: Forty-six female outpatients meeting DSM-IV criteria for OCD completed a semistructured interview at our OCD unit to assess the relationship between reproductive cycle events and OCD. Dates of data collection were from January 2001 to December 2003.
RESULTS: In our sample, OCD onset occurred in the same year as menarche in 22% (N = 10), at pregnancy in 2% (N = 1), at postpartum in 7% (N = 3), and at menopause in 2% (N = 1). Worsening of preexisting OCD was reported by 20% of patients (9/45) at premenstruum, 8% (1/12) at pregnancy, 50% (6/12) at postpartum, and 8% (1/12) at menopause. The number of premenstrual mood symptoms, which included anxiety, irritability, mood lability and depressed mood, was associated with both premenstrual worsening of OCD (OR = 5.1, p < .01) and onset or worsening of OCD at postpartum (OR = 2.7, p < .05). Patients with an onset or worsening of OCD at postpartum also more frequently reported pre-menstrual worsening of OCD and previous history of major depressive disorder, including postpartum depression (p < or =.05 for all).
CONCLUSION: In a substantial number of patients, the onset or worsening of OCD was related to reproductive cycle events, especially at menarche and postpartum. Certain women with OCD seem to be vulnerable to worsening of OCD at different reproductive periods that imply hormonal fluctuations, and premenstruum and post-partum were the 2 reproductive events with a greater vulnerability. Those patients whose OCD symptoms appeared to be related to reproductive events also exhibited a greater history of mood symptoms (premenstrual depression and major depressive episodes).

Entities:  

Mesh:

Year:  2005        PMID: 15816784     DOI: 10.4088/jcp.v66n0404

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  34 in total

Review 1.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

2.  Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone.

Authors:  Tory A Eisenlohr-Moul; C Nathan DeWall; Susan S Girdler; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2015-03-30       Impact factor: 3.251

Review 3.  Mother-infant bonding and the evolution of mammalian social relationships.

Authors:  K D Broad; J P Curley; E B Keverne
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

4.  Compulsive hoarding associated with abortion.

Authors:  Sanjeev Sockalingam; Marcia Zemans
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-11

5.  Effects of gender and executive function on visuospatial working memory in adult obsessive-compulsive disorder.

Authors:  Riccardo Maria Martoni; Giulia Salgari; Elisa Galimberti; Maria Cristina Cavallini; Joseph O'Neill
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-14       Impact factor: 5.270

Review 6.  Recognizing and Managing Postpartum Psychosis: A Clinical Guide for Obstetric Providers.

Authors:  Lauren M Osborne
Journal:  Obstet Gynecol Clin North Am       Date:  2018-09       Impact factor: 2.844

7.  A CASE OF PERIPARTUM OBSESSIVE-COMPULSIVE DISORDER: The Potential Role of Corticosteroids, Gonadal Steroids, and the Neuropeptide Oxytocin in its Pathogenesis.

Authors:  David R Spiegel; Kathyrn Sommese; Anastasia Turenkov; Niels Naimon
Journal:  Innov Clin Neurosci       Date:  2019-05-01

8.  Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.

Authors:  Lieselot L G Carrette; Roy Blum; Weiyuan Ma; Raymond J Kelleher; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

9.  Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium.

Authors:  Shirin Namouz-Haddad; Irena Nulman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 10.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.